Trial Profile
An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin Tablets, 20 mg, for the Management of Essential Hypertension
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 23 Sep 2021
Price :
$35
*
At a glance
- Drugs Bexagliflozin (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Theracos
- 07 Dec 2018 Status changed from active, no longer recruiting to completed.
- 07 May 2018 New trial record